VASCULAR PATCHES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

Vascular patches are used for reconstruction of a damaged artery in the cardiovascular surgeries. It is usually placed at the site infection, which helps in reconstruction and maintenance of carotid arteries in postoperative wound infection. The vascular patches allows positive and safe angioplasty of an artery to be performed in an infected operation site.

Market Dynamics

Rising aging population is expected to drive the global vascular patches market growth. For instance, according to an article published by the World Health Organization (WHO) in February 2018, the proportion of the worldwide geriatric population will nearly double from 12% to 22% between 2015 and 2050.

Moreover, the rising prevalence of cardiovascular diseases is expected to drive the market growth. For instance, according to an article titled ‘Heart Disease and Stroke Statistics-2019’, published by the American College of Cardiology Foundation in 2019, around 795,000 U.S. populace have new or recurrent stroke annually, in which 90.0% of stroke risk is due to modifiable risk factors and 74.0% is due to behavioral risk factors.

Key features of the study

• This report provides in-depth analysis of the global vascular patches market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global vascular patches market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans.
• Key companies covered as a part of this study include B. Braun Melsungen AG, C. R. Bard, Inc., LeMaitre Vascular, Inc., Getinge AB (Maquet), W. L. Gore & Associates, Inc., Edwards Lifesciences Corporation, Baxter International Inc., CryoLife, Inc., Medtronic, and Admedus, among others.
• Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics.
• The global vascular patches market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vascular patches market.

Market Segmentation

• Global Vascular Patches Market, By Type
  • Biologic Vascular Patches
  • Synthetic Vascular Patches
• Global Vascular Patches Market, By Application
  • Carotid Endarterectomy
  • Aortic Aneurysms
  • Profundaplasty
  • Others
• Global Vascular Patches Market, By End User
  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others
• Global Vascular Patches Market, By Region
  • North America
    • By Type
      • Biologic Vascular Patches
      • Synthetic Vascular Patches
    • By Application
      • Carotid Endarterectomy
      • Aortic Aneurysms
      • Profundaplasty
      • Others
    •  By End User
      • Hospitals and Clinics
      • Ambulatory Surgical Centers
      • Others
    • By Country
      • U.S.
      • Canada
  • Latin America
    • By Type
      • Biologic Vascular Patches
      • Synthetic Vascular Patches
    • By Application
      • Carotid Endarterectomy
      • Aortic Aneurysms
      • Profundaplasty
      • Others
    •  By End User
      • Hospitals and Clinics
      • Ambulatory Surgical Centers
      • Others
    • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Type
      • Biologic Vascular Patches
      • Synthetic Vascular Patches
    • By Application
      • Carotid Endarterectomy
      • Aortic Aneurysms
      • Profundaplasty
      • Others
    •  By End User
      • Hospitals and Clinics
      • Ambulatory Surgical Centers
      • Others
    • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Type
      • Biologic Vascular Patches
      • Synthetic Vascular Patches
    • By Application
      • Carotid Endarterectomy
      • Aortic Aneurysms
      • Profundaplasty
      • Others
    •  By End User
      • Hospitals and Clinics
      • Ambulatory Surgical Centers
      • Others
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Type
      • Biologic Vascular Patches
      • Synthetic Vascular Patches
    • By Application
      • Carotid Endarterectomy
      • Aortic Aneurysms
      • Profundaplasty
      • Others
    •  By End User
      • Hospitals and Clinics
      • Ambulatory Surgical Centers
      • Others
    • By Country
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Type
      • Biologic Vascular Patches
      • Synthetic Vascular Patches
    • By Application
      • Carotid Endarterectomy
      • Aortic Aneurysms
      • Profundaplasty
      • Others
    •  By End User
      • Hospitals and Clinics
      • Ambulatory Surgical Centers
      • Others
    • By Country/Region
      • South Africa
      • Central Africa
      • North Africa
• Company Profiles
  • B. Braun Melsungen AG 
  • C. R. Bard, Inc.
  • LeMaitre Vascular, Inc.
  • Getinge AB (Maquet)
  • W. L. Gore & Associates, Inc.
  • Edwards Lifesciences Corporation
  • Baxter International Inc.
  • CryoLife, Inc.
  • Medtronic
  • Admedus